期刊
CLINICS IN PERINATOLOGY
卷 39, 期 1, 页码 111-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.clp.2011.12.002
关键词
Patent ductus arteriosus (PDA); Hemodynamically significant PDA (hsPDA); Indomethacin; Ibuprofen; Prematurity; Intraventricular hemorrhage (IVH); Necrotizing enterocolitis (NEC); Spontaneous intestinal perforation (SIP)
资金
- NIH [HL77395, HL96967, HL109199]
Indomethacin and ibuprofen are potent inhibitors of prostaglandin synthesis. Neonates have been exposed to these compounds for more than 3 decades. Indomethacin is commonly used to prevent intraventricular hemorrhage (IVH), and both drugs are prescribed for the treatment or prevention of patent ductus arteriosus (PDA). This review examines the basis for indomethacin and ibuprofen use in the neonatal intensive care population. Despite the call for restrained use of each drug, the most immature infants are likely to need pharmacologic approaches to reduce high-grade IVH, avoid the need for PDA ligation, and preserve the opportunity for an optimal outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据